While the government has ordered a study on preferential treatment for domestic new drugs developed by innovative pharmaceutical companies, domestic pharmaceutical companies with new drug technology are expressing both expectations and concerns at the same time.

As the government accepts demands from the pharmaceutical industry and criticism from the National Assembly, many pharmaceutical companies think positively about the possibility of enacting a sub-law on innovative new drugs in the Special Act on the Pharmaceutical Industry within next year. International trade friction is not a problem that can be solved by the MOHW alone, but trade pressure-related ministries such as the Ministry of Commerce,